These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9215609)
21. Acute myeloblastic leukemia. Molina CA; Rodríguez MJ; de Marcos NS; Font P Adv Ther; 2011 Mar; 28 Suppl 3():10-6. PubMed ID: 21431629 [TBL] [Abstract][Full Text] [Related]
22. Occurrence of myelodysplasia/acute myeloid leukemia 'on therapy' in two patients with acute promyelocytic leukemia. Chelghoum Y; Plesa A; Ducastelle S; Elhamri M; Thomas X Indian J Cancer; 2016; 53(1):59-60. PubMed ID: 27146742 [No Abstract] [Full Text] [Related]
24. Differentiation in acute myeloid leukemia and myelodysplastic disorders. Is differentiation-induction therapy possible? Januszewicz EH; Firkin FC Aust N Z J Med; 1988 Aug; 18(5):705-11. PubMed ID: 3072952 [TBL] [Abstract][Full Text] [Related]
25. Low dose cytosine arabinoside in myelodysplasia and acute myelogenous leukemia: a review. Bolwell BJ; Cassileth PA; Gale RP Leukemia; 1987 Aug; 1(8):575-9. PubMed ID: 3312846 [TBL] [Abstract][Full Text] [Related]
26. Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia. Frankel A; Liu JS; Rizzieri D; Hogge D Leuk Lymphoma; 2008 Mar; 49(3):543-53. PubMed ID: 18297533 [TBL] [Abstract][Full Text] [Related]
27. Very-low-dose cytarabine for myelodysplastic syndromes and acute myeloid leukaemia in the elderly. Worsley A; Mufti GJ; Copplestone JA; Oscier DG; Hamblin TJ Lancet; 1986 Apr; 1(8487):966. PubMed ID: 2871254 [No Abstract] [Full Text] [Related]
28. Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related Acute Myeloid Leukemia (AML) or AML With Myelodysplasia-Related Changes. Kim M; Williams S Ann Pharmacother; 2018 Aug; 52(8):792-800. PubMed ID: 29532662 [TBL] [Abstract][Full Text] [Related]
30. Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes. Murray M; Sarsfield P; Lawlor E; McCann SR Ir J Med Sci; 1988 Jul; 157(7):238-41. PubMed ID: 3170148 [No Abstract] [Full Text] [Related]
32. Decitabine improves platelet recovery by down-regulating IL-8 level in MDS/AML patients with thrombocytopenia. Zhang W; Liu C; Wu D; Liang C; Zhang L; Zhang Q; Liu Y; Xia M; Wang H; Su P; Feng S; Han M; Zhou J; Wang F; Jiang E Blood Cells Mol Dis; 2019 May; 76():66-71. PubMed ID: 30846359 [No Abstract] [Full Text] [Related]
33. [Therapeutic effectiveness of vitamin D3 in patients with myelodysplastic syndromes, leukemias and myeloproliferative disorders]. Takahashi T; Ichiba S; Okuno Y; Sugiyama H; Sakai Y; Imura H; Iho S; Hoshino T; Suzuki A; Okada T Rinsho Ketsueki; 1989 Jan; 30(1):1-10. PubMed ID: 2716194 [TBL] [Abstract][Full Text] [Related]
34. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. Koeffler HP; Hirji K; Itri L Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438 [TBL] [Abstract][Full Text] [Related]
35. [Effect of low-dose Ara-C in the treatment of refractory, atypical leukemia and myelodysplastic syndrome]. Tsubaki K; Horiuchi A; Nagai K; Kanamaru A; Kohsaki M; Kitani T; Tagawa S; Masaoka T; Shibata H; Yasunaga K Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):996-1003. PubMed ID: 3457553 [TBL] [Abstract][Full Text] [Related]